SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-046186
Filing Date
2017-07-25
Accepted
2017-07-25 16:45:53
Documents
2
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1558
2 POA DOCUMENT poa.txt EX-24.3_737680 3892
  Complete submission text file 0001209191-17-046186.txt   6836
Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BLVD. BRISBANE CA 94005
Business Address
Verwiel Frank (Reporting) CIK: 0001545794 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 17980832

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances